NPI: 1679673917 · LELAND, MS 38756 · 261QR1300X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 6,812 | $403K |
| 2019 | 6,018 | $468K |
| 2020 | 5,815 | $504K |
| 2021 | 6,966 | $623K |
| 2022 | 8,012 | $592K |
| 2023 | 5,098 | $439K |
| 2024 | 1,493 | $77K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99212 | 12,435 | 10,160 | $1.24M | |
| 99213 | 13,971 | 11,050 | $1.11M | |
| 90834 | 5,270 | 3,381 | $512K | |
| 99202 | 746 | 632 | $66K | |
| 90792 | 369 | 356 | $44K | |
| 99201 | 422 | 373 | $42K | |
| 99214 | 194 | 168 | $16K | |
| G2025 | Dis site tele svcs rhc/fqhc | 755 | 476 | $15K |
| 99392 | 157 | 103 | $12K | |
| 96372 | 781 | 690 | $8K | |
| 90791 | 111 | 78 | $8K | |
| 90785 | 1,292 | 720 | $8K | |
| 99382 | 55 | 49 | $4K | |
| 36415 | 2,132 | 1,644 | $4K | |
| 81025 | 276 | 239 | $3K | |
| 83036 | 139 | 121 | $2K | |
| 99215 | Prolong outpt/office vis | 58 | 37 | $2K |
| G0467 | Fqhc visit, estab pt | 84 | 71 | $2K |
| 80061 | 55 | 50 | $380.52 | |
| 87804 | 74 | 67 | $380.52 | |
| 81003 | 43 | 39 | $270.86 | |
| 99205 | Prolong outpt/office vis | 34 | 14 | $140.53 |
| 90756 | 56 | 47 | $128.74 | |
| 36416 | 14 | 12 | $126.84 | |
| J1030 | Methylprednisolone 40 mg inj | 126 | 105 | $2.56 |
| J1100 | Dexamethasone sodium phos | 318 | 264 | $0.20 |
| J1040 | Methylprednisolone 80 mg inj | 42 | 39 | $0.00 |
| 92551 | 16 | 12 | $0.00 | |
| 90471 | 88 | 65 | $0.00 | |
| J1010 | Inj, methylpred acetate 1 mg | 14 | 14 | $0.00 |
| 92507 | 34 | 14 | $0.00 | |
| 90686 | 27 | 26 | $0.00 | |
| J0696 | Ceftriaxone sodium injection | 26 | 25 | $0.00 |